fbpx
 

Zantac | CBS News | October 9, 2019 There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled the drugs off shelves, following an FDA...

The Japan Times | October 1, 2019 BANGALORE, INDIA – GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution,” days after the U.S. Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug. Zantac,...